Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer
- PMID: 12743164
- DOI: 10.1200/JCO.2003.99.089
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
